Search results for "Androgen"

showing 10 items of 326 documents

Mutations of the androgen receptor gene in patients with complete androgen insensitivity.

1997

MaleAndrogen Receptor GeneDisorders of Sex DevelopmentBiologyAndrogen-Insensitivity SyndromePolymerase Chain ReactionAndrogen receptorReceptors AndrogenMutationGeneticsCancer researchHumansIn patientFemaleComplete androgen insensitivityGenetics (clinical)Polymorphism Single-Stranded ConformationalHuman mutation
researchProduct

Metronomic cyclophosphamide induces regulatory T cells depletion and PSA‐specific T cells reactivation in patients with biochemical recurrent prostat…

2019

Biochemical recurrence (BCR) occurs in up to 40% of prostate cancer patients after prostatectomy. In our study, we performed an immune monitoring study in 20 prostate cancer patients with BCR previously treated with metronomic cyclophosphamide (mCTX). We observed a decrease of regulatory T cells (Tregs) from 2 months and this was more pronounced after 6 months of mCTX treatment. This drop of Tregs was associated with increased level of activated HLADR+ CD45R0+ T cells in peripheral blood. Furthermore, a reactivation of Th1 polarized anti-PSA T-cell response was detected in BCR patients treated with mCTX. However, dendritic cell subsets counts and activation were not influenced by the treatm…

MaleBiochemical recurrenceCancer ResearchT-Lymphocytesmedicine.medical_treatmentLymphocyte ActivationT-Lymphocytes RegulatoryLymphocyte DepletionAndrogen deprivation therapy03 medical and health sciencesProstate cancer0302 clinical medicinemedicineHumansAntineoplastic Agents AlkylatingCyclophosphamideMetronomic cyclophosphamideDiminutionProstatectomybusiness.industrybreakpoint cluster regionProstatic NeoplasmsDendritic cellProstate-Specific Antigenmedicine.diseaseOncology030220 oncology & carcinogenesisAdministration MetronomicCancer researchNeoplasm Recurrence LocalbusinessInternational Journal of Cancer
researchProduct

Distribution of nitroreductive activity toward nilutamide in rat.

2004

Abstract Nilutamide is a pneumotoxic and hepatotoxic nitroaromatic (R-NO 2 ) antiandrogen used in the treatment of prostate carcinoma in man. Previously, we established that in the rat lung, the drug is metabolized into the corresponding hydroxylamine (R-NHOH) and amine (R-NH 2 ) derivatives. These results evidenced a cytosolic oxygen-sensitive (type II) nitroreductase activity in lung. In the present studies, we extended the characterization of nilutamide metabolism in liver, brain, kidney, heart, blood, intestine (small, cecum, and large, and their respective luminal contents) of male Sprague–Dawley rats. Subcellular fractions for all tissues (except blood) examined (postmitochondrial, cy…

MaleBiologyToxicologyImidazolidinesKidneyRats Sprague-DawleyNitroreductaseCecumCytosolmedicineAnimalsIntestinal MucosaCells CulturedChromatography High Pressure LiquidPharmacologyKidneyBrainAndrogen AntagonistsMetabolismNitroreductasesSmall intestineRatsCytosolmedicine.anatomical_structureBiochemistryLiverNilutamideMicrosomemedicine.drugToxicology and applied pharmacology
researchProduct

Polychlorinated biphenyls affect histone modification pattern in early development of rats: a role for androgen receptor-dependent modulation?

2012

Background: The epigenome represents an important target of environmental pollution. Early-life exposure to polychlorinated biphenyls (PCBs) modifies sex steroid enzymes and receptor transcription patterns. Steroid receptors, such as androgen receptor (AR), function as coregulators of histone modification enzymes. Aim: To clarify if a PCB early-life exposure might affect the epigenome in rat liver, we analyzed some histone post-translational modifications (H3K4me3 and H4K16Ac) and the corresponding histone remodeling enzymes, and the AR as a histone enzyme coregulator. Results: We observed a decrease of H4K16Ac and H3K4me3 levels, possibly linked to the induction of chromatin-modifying enz…

MaleCancer Researchmedicine.medical_specialtyJumonji Domain-Containing Histone DemethylasesTranscription GeneticEnvironmental pollutionMethylationEpigenesis GeneticHistonesRats Sprague-DawleySirtuin 1PregnancyInternal medicineGeneticsmedicineAnimalsHumansEpigeneticsReceptorbiologyEpigenomeDNA MethylationPolychlorinated BiphenylsRatsAndrogen receptorEndocrinologyHistoneHEK293 CellsLiverSex steroidReceptors AndrogenPrenatal Exposure Delayed Effectsbiology.proteinH3K4me3CpG IslandsEnvironmental PollutantsFemaleEpigenomics
researchProduct

Effects of phenylbutyrate on proliferation and apoptosis in human prostate cancer cells in vitro and in vivo.

1999

Phenylbutyrate (PB) is a potent differentiating agent and currently under investigation for the treatment of prostate cancer (CaP) and other malignancies. We have studied the impact of PB in vitro and in vivo on differentiation, proliferation and apoptosis in the LNCaP and LuCaP 23.1 prostate cancer xenograft models. In vitro we found that i) PB increased PSA secretion/cell, ii) inhibited cell proliferation in a time- and dose-dependent manner resulting in a cell cycle arrest in G1-phase and iii) induced apoptosis at concentrations of 2.5 mM after 3 days of treatment. In PB treated animals tumor growth stabilized or regressed. Combination of castration and PB treatment had a synergistic ant…

MaleCancer Researchmedicine.medical_specialtyProgrammed cell deathTransplantation HeterologousMice NudeAntineoplastic AgentsApoptosisBiologyPhenylbutyrateMiceProstate cancerIn vivoInternal medicineLNCaPTumor Cells CulturedmedicineAnimalsHumansMice Inbred BALB CCell growthCell CycleProstatic NeoplasmsCancerCell Differentiationmedicine.diseasePhenylbutyratesDisease Models AnimalEndocrinologyOncologyCancer cellAndrogensCancer researchCell DivisionNeoplasm TransplantationInternational Journal of Oncology
researchProduct

Nitric oxide-mediated inhibition of androgen receptor activity: possible implications for prostate cancer progression.

2006

Chronic inflammation increases the risk of cancer and many cancers, including prostate cancer, arise at sites of chronic inflammation. Inducible nitric oxide synthase (iNOS) is an enzyme dominantly expressed during inflammatory reactions. Although synthesis of high amounts of nitric oxide (NO) by iNOS has been demonstrated in pathophysiological processes, such as acute or chronic inflammation, autoimmune diseases or tumorigenesis, the role of iNOS activity in most of these diseases is poorly understood. Analysing prostate cancer biopsies by immunohistochemistry we found iNOS protein expression in tumor cells strongly paralleled by nitrotyrosine suggesting that iNOS is fully active. In vitro…

MaleCancer Researchmedicine.medical_specialtymedicine.drug_classNitric Oxide Synthase Type IIBiologymedicine.disease_causeNitric OxideProstate cancerProstateInternal medicineCell Line TumorGeneticsmedicineAndrogen Receptor AntagonistsHumansAndrogen Receptor AntagonistsMolecular BiologyReverse Transcriptase Polymerase Chain ReactionCancerProstatic NeoplasmsAndrogenmedicine.diseaseImmunohistochemistryAndrogen receptormedicine.anatomical_structureEndocrinologyTumor progressionReceptors AndrogenDisease ProgressionCarcinogenesisOncogene
researchProduct

Genotyping of sex hormone-related pathways in benign and malignant human prostate tissues: data of a preliminary study.

2011

Prostate cancer (PCa) is a major health issue in Westernized countries, representing a common cause of morbidity and mortality in the elderly male population. Endogenous sex steroids, along with environmental factors (notably diet) and host immune and inflammatory responses, are likely to cooperate in the pathogenesis of the disease. Based on the assumption that a complex endocrine–inflammatory-immune interaction is primarily implicated in human PCa, we have investigated the interplay between sex steroids and inflammation in development and growth of human PCa. To this end, we have assessed nine functional single nucleotide polymorphisms (SNP)s of five genes involved in sex hormone-related …

MaleGenotypeProstatic HyperplasiaSingle-nucleotide polymorphismDiseaseBioinformaticsBiochemistryPolymorphism Single NucleotideCohort StudiesProstate cancerSex hormone-binding globulinAromataseprostate cancer sex hormone related pathways3-Oxo-5-alpha-Steroid 4-DehydrogenaseGene FrequencyGeneticsmedicineSNPHumansMolecular BiologyAllele frequencyGenotypingSicilyGenetic Association StudiesAgedSettore MED/04 - Patologia GeneraleAged 80 and overbiologyCase-control studyMembrane ProteinsProstatic NeoplasmsSequence Analysis DNAMiddle Agedmedicine.diseaseReceptors EstrogenReceptors AndrogenCase-Control StudiesImmunologybiology.proteinMolecular MedicineBiotechnologyOmics : a journal of integrative biology
researchProduct

Prevalence and clinical features of polycystic ovarian syndrome in adolescents with previous childhood growth hormone deficiency.

2016

AbstractGrowth hormone (GH) plays a role in the regulation of ovarian function but there are limited data in women with GH deficiency (GHD). Our aim was to evaluate the features of polycystic ovarian syndrome (PCOS) in women with previous GHD.Data of 22 adolescents previously GH-treated (group A) were compared with those of 22 women with classical PCOS (group B) and 20 controls (group C).: Group A showed higher testosterone (p=0.048) and prevalence of menstrual irregularities (p<0.001) than group C. Compared to the group B, group A showed lower diastolic blood pressure (p=0.004), degree of hirsutism (p=0.005), testosterone (p=0.003) and prevalence of polycsytic ovaries (POC) morphology (…

MaleHirsutismmedicine.medical_specialtyAdolescentChildhood growthEndocrinology Diabetes and Metabolism030209 endocrinology & metabolismGroup AGroup BSettore MED/13 - Endocrinologia03 medical and health sciences0302 clinical medicineEndocrinologyInternal medicinePrevalenceHumansMedicineTestosteroneProspective StudiesChildGrowth DisordersMenstruation DisturbancesTestosteronehirsutism030219 obstetrics & reproductive medicineEstradiolHuman Growth Hormonebusiness.industryPrognosismedicine.diseaseGrowth hormone polycystic ovarian syndromeEndocrinologyBlood pressureItalyCase-Control StudiesPediatrics Perinatology and Child HealthFemaleHyperandrogenismbusinessBiomarkersGH DeficiencyFollow-Up StudiesPolycystic Ovary SyndromeHormone
researchProduct

Metabolism of nilutamide in rat lung.

2005

Nilutamide is a non-steroidal anti-androgen drug proposed in the treatment of metastatic prostatic carcinoma. Its therapeutic effects are overshadowed by the occurrence of adverse reactions, mediated by mechanisms that remain elusive. To elucidate possible mechanisms for nilutamide toxicity, we investigated the metabolism of nilutamide in rat lung homogenates, in subcellular fractions and in freshly isolated cells. In whole lung homogenates, the nitro group of nilutamide was reduced to the amine and hydroxylamine moieties. These conversions occurred exclusively in the absence of dioxygen, were increased by the addition of FMN, FAD, or NADPH. Reductive metabolism of nilutamide to the amine a…

MaleIn Vitro TechniquesImidazolidinesBiochemistryCofactorMass SpectrometryRats Sprague-Dawleychemistry.chemical_compoundHydroxylamineCytosolMacrophages AlveolarmedicineAnimalsEnzyme InhibitorsLungChromatography High Pressure LiquidPharmacologychemistry.chemical_classificationbiologyAndrogen AntagonistsEpithelial CellsMetabolismRatsNitric oxide synthaseCytosolKineticsEnzymeBiochemistrychemistryNilutamidebiology.proteinOxidation-ReductionDrug metabolismmedicine.drugChromatography LiquidBiochemical pharmacology
researchProduct

EARLY CHOLINE LEVELS FROM 3-TESLA MR SPECTROSCOPY AFTER EXCLUSIVE RADIATION THERAPY IN PATIENTS WITH CLINICALLY LOCALIZED PROSTATE CANCER ARE PREDICT…

2011

International audience; Abstract: Purpose: To investigate the time course response of prostate metabolism to irradiation using magnetic resonance spectroscopy (MRS) at 3-month intervals and its impact on biochemical control. Methods and Materials: Between January 2008 and April 2010, 24 patients with localized prostate cancer were prospectively enrolled in the Evaluation of the Response to Irradiation with MR Spectroscopy (ERIS) trial. All the patients had been treated with intensity-modulated radiation therapy with or without long-term adjuvant hormonal therapy (LTHT) and underwent 3-T MRS and prostate-specific antigen (PSA) assays at baseline and every 3 months thereafter up to 12 months.…

MaleIn vivo magnetic resonance spectroscopyCancer ResearchTime Factorsmedicine.medical_treatmentCholine030218 nuclear medicine & medical imagingchemistry.chemical_compoundProstate cancer0302 clinical medicineProstateCholineProspective StudiesProspective cohort studyProstate cancerRadiation[ INFO.INFO-IM ] Computer Science [cs]/Medical ImagingProstateOrgan SizeMiddle AgedTumor Burdenmedicine.anatomical_structureOncologyChemotherapy Adjuvant030220 oncology & carcinogenesisPredictive value of testsHormonal therapyResponse monitoringmedicine.medical_specialtyUrologyCitric Acid03 medical and health sciencesBody WaterPredictive Value of TestsMagnetic resonance spectroscopymedicine[INFO.INFO-IM]Computer Science [cs]/Medical ImagingHumansRadiology Nuclear Medicine and imagingAgedbusiness.industryProstatic NeoplasmsAndrogen AntagonistsProstate-Specific Antigenmedicine.diseaseRadiation therapychemistryRadiotherapy Intensity-Modulated3 TeslabusinessNuclear medicine
researchProduct